nicotine has been researched along with anisodamine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liu, X; Qin, Z; Su, DF; Sun, Y; Xiang, K | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
2 other study(ies) available for nicotine and anisodamine
| Article | Year |
|---|---|
Activation of the Cholinergic Anti-Inflammatory Pathway as a Novel Therapeutic Strategy for COVID-19.
Topics: Acupuncture; Anti-Inflammatory Agents; COVID-19; Cytokine Release Syndrome; Cytokines; Drugs, Chinese Herbal; Humans; Inflammation; Neuroimmunomodulation; Nicotine; SARS-CoV-2; Solanaceous Alkaloids; Vagus Nerve; Vagus Nerve Stimulation | 2020 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |